These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 266969)
1. HLA linked resistance factors and survival in acute myelogenous leukemia. Oliver RT; Pillai A; Klouda PT; Lawler SD Cancer; 1977 Jun; 39(6):2337-41. PubMed ID: 266969 [TBL] [Abstract][Full Text] [Related]
2. HLA-A and HLA-B antigens in acute leukemia: A2--B12 phenotypes correlate with longer survival in acute myelogenous leukemia. von Fliedner VE; Sultan Khan Z; Jeannet M Acta Haematol; 1981; 65(2):73-8. PubMed ID: 6785965 [TBL] [Abstract][Full Text] [Related]
3. HLA-B17 and the HLA-A1, B17 haplotype in acute myelogenous leukemia. Heise E; Parrish E; Cooper R Tissue Antigens; 1979 Aug; 14(2):98-104. PubMed ID: 291140 [TBL] [Abstract][Full Text] [Related]
4. Preliminary study of HLA-ABCDR antigens in CML, ANLL, thalassemia and severe aplastic anemia in Thais. Chiewsilp P; Sujirachato K; Mongkolsuk T; Junpong S; Jootar S; Hathirat P J Med Assoc Thai; 2000 Mar; 83 Suppl 1():S130-6. PubMed ID: 10865419 [TBL] [Abstract][Full Text] [Related]
5. [Association between HLA antigens and leukemia in the population of Vojvodina]. Vojvodić S; Belić B; Popović S Med Pregl; 2001; 54(3-4):128-34. PubMed ID: 11759203 [TBL] [Abstract][Full Text] [Related]
6. Studies on HLA antigens and cellular and humoral autoimmune phenomena in patients with myasthenia gravis. Gross WL; Krüger J; Gröschel-Stewart U; Friedrich H; Kunze K Clin Exp Immunol; 1977 Jan; 27(1):48-54. PubMed ID: 849650 [TBL] [Abstract][Full Text] [Related]
10. Possible effects of non-HLA antibodies in common typing sera on HLA antigen frequency data in leukemia. Pollack MS; DuBois D Cancer; 1977 Jun; 39(6):2348-54. PubMed ID: 301430 [TBL] [Abstract][Full Text] [Related]
11. HLA frequencies in cancer: a third study. Perdue ST; Terasaki PI; Mickey MR IARC Sci Publ (1971); 1978; (20):263-9. PubMed ID: 282233 [TBL] [Abstract][Full Text] [Related]
12. The HLA polymorphism and susceptibility to disease. Mittal KK Vox Sang; 1976; 31?-73(3):161-73. PubMed ID: 969389 [TBL] [Abstract][Full Text] [Related]
13. Influence of HLA, ABO, and Rh(D) on survival after remission in acute myelogenous leukaemia. Harris R; Zuhrie SR; Taylor GM; Freeman CB; Wentzel J; Geary C; MacIver JE Lancet; 1977 Sep; 2(8039):653. PubMed ID: 71463 [No Abstract] [Full Text] [Related]
14. A raised incidence of HL-A2 plus HL-A9 and other anomalies of the HL-A antigens of patients with leukaemia. Dickson A Acta Haematol; 1975; 54(3):143-51. PubMed ID: 809957 [TBL] [Abstract][Full Text] [Related]
15. Frequency of HLA antigens in chronic myelocytic leukemia. Hester JP; Rossen R; Trujillo J; McCredie KB; Freireich EJ South Med J; 1977 Jun; 70(6):691-3. PubMed ID: 69321 [TBL] [Abstract][Full Text] [Related]
17. HLA patterns in pernicious anaemia. Ungar B; Mathews JD; Tait BD; Cowling DC Br Med J; 1977 Mar; 1(6064):798-800. PubMed ID: 856385 [TBL] [Abstract][Full Text] [Related]
18. [The impact of HLA high resolution typing mismatching of donor-recipient pairs on outcome of unrelated donor hematopoietic stem cell transplantation]. He J; Xu C; Wu XJ; Bao XJ; Qiu QC; Yuan XN; Li Y; Shen HJ; Wu DP; Hong JL; Liu JH; DU HY; Zhang L; DU D; Lu J; Liu J Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):353-7. PubMed ID: 22781790 [TBL] [Abstract][Full Text] [Related]
19. HLA and chronic active hepatitis (CAH). Dumble LJ; Mackay IR Digestion; 1977; 15(4):254-9. PubMed ID: 863129 [TBL] [Abstract][Full Text] [Related]
20. Lack of association between Hashimoto's thyroiditis and SD-locus HLA antigens. Ludwig H; Schernthaner G; Mayr WR; Höfer R Diabete Metab; 1977 Jun; 3(2):127-30. PubMed ID: 578140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]